In Q2 2025, Nano-X reported $3.04 million in revenue, a modest increase driven by growth in its teleradiology segment. However, the company reported a net loss of $14.7 million and a gross loss margin of 37.2%, as it continues investing in commercialization efforts for its imaging systems and AI platforms. Cash reserves decreased to $58.3 million, and the company reaffirmed its focus on product deployment and expanding imaging services.
Revenue reached $3.04 million, with growth led by teleradiology services
GAAP gross loss margin was 37.2%, driven by operating costs and rollout expenses
Net loss widened to $14.7 million, up from $12.1 million YoY
Cash balance declined to $58.3 million as the company continued deploying imaging systems
Nano-X plans to continue deploying its ARC systems globally and scaling teleradiology services, while managing cost structure and driving adoption of its AI technologies.
Analyze how earnings announcements historically affect stock price performance